111 |
Antonella Folgori, on behalf of ReiThera, Italy |
Antonella Folgori, on behalf of ReiThera, Italy |
|
112 |
Thomas Friedrich, University of Wisconsin, School of Veterinary Medicine, USA |
Thomas Friedrich, University of Wisconsin, School of Veterinary Medicine, USA |
|
113 |
Simon Funnel, Public Health England, UK |
Simon Funnel, Public Health England, UK |
|
114 |
Luc Gagnon, Nexelis, Canada |
Luc Gagnon, Nexelis, Canada |
|
115 |
Adolfo Garcia-Sastre, Icahn School of Medicine at Mount Sinai, USA |
Adolfo Garcia-Sastre, Icahn School of Medicine at Mount Sinai, USA |
|
116 |
Vipin Garg, Altimmune Inc., USA |
Vipin Garg, Altimmune Inc., USA |
|
117 |
Volker Gerdts, on behalf of VIDO-Intervac, University of Saskatchewan, Canada |
Volker Gerdts, on behalf of VIDO-Intervac, University of Saskatchewan, Canada |
|
118 |
Nora Gerhards, Wageningen Bioveterinary Research, The Netherlands |
Nora Gerhards, Wageningen Bioveterinary Research, The Netherlands |
|
119 |
Christiane Gerke, Head of Vaccine Programs/Head of Vaccine Innovation Development, Institut Pasteur, France |
Christiane Gerke, Head of Vaccine Programs/Head of Vaccine Innovation Development, Institut Pasteur, France |
|
120 |
Carlo Giaquinto, Department of Women and Child Health, University of Padova, Italy |
Carlo Giaquinto, Department of Women and Child Health, University of Padova, Italy |
|